I. Hay

J. Shah, A. Sanabria, A. Mäkitie, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Thyroid cancer: Overdiagnosis of papillary carcinoma — who benefits?

J. Brito, I. Hay, 2017, Nature Reviews Endocrinology.

Role of Radioactive Iodine for Remnant Ablation in Patients with Papillary Thyroid Cancer

I. Hay, Nicole M. Iñiguez-Ariza, Suneetha Kaggal, 2017 .

A Case of a Papillary Thyroid Cancer with Lymph Node Metastases Found on Prophylactic Central Neck Dissection (Subclinical Disease, Micrometastases)

I. Hay, 2016 .

Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance

M. Castro, J. Brito, I. Hay, 2015, Cancer.

Surgery for Benign Thyroid Disease

K. Boelaert, I. Hay, S. Jayaram, 2014 .

Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.

J. Charboneau, C. Reading, I. Hay, 2013, Surgery.

Reoperative Experience with Papillary Thyroid Cancer

D. Farley, J. Kasperbauer, G. Thompson, 2014, World Journal of Surgery.

Is Prophylactic Central Compartment Lymph Node Dissection Necessary for Papillary Thyroid Carcinoma

G. Thompson, I. Hay, C. Grant, 2010 .

Managing Patients with a Preoperative Diagnosis of AJCC/UICC Stage I (T1N0M0) Papillary Thyroid Carcinoma: East Versus West, Whose Policy is Best?

I. Hay, 2010, World Journal of Surgery.

Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma.

J. Charboneau, C. Reading, I. Hay, 2002, AJR. American journal of roentgenology.

Papillary thyroid microcarcinoma : a study of 535 cases observed in a 50-year period: Discussion

E. Bergstralh, B. Cady, E. Bergstralh, 1992 .

The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT

V. Lowe, C. Reading, J. Kasperbauer, 2007, Nuclear medicine communications.

Management of differentiated thyroid cancer

I. Hay, S. Grebe, 1995 .

Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

I. Hay, S. Grebe, 1996, Surgical oncology clinics of North America.

American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. The Committee on Nomenclature of the American Thyroid Association.

P. Larsen, G. Klee, I. Hay, 1991, Clinical chemistry.

Medullary thyroid carcinoma: role of high-resolution US.

H. Gharib, J. Charboneau, C. Reading, 1987, Radiology.

Locally invasive papillary thyroid carcinoma: 1940–1990

E. Bergstralh, E. Bergstralh, I. Hay, 1994, Head & neck.

Serum thyroglobulin in differentiated thyroid cancer.

C. Gorman, I. Hay, 1979, British medical journal.

Papillary Thyroid Carcinoma

I. Hay, 1990 .

Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma.

M. Reinalda, G. Thompson, G. Wiseman, 2021, Mayo Clinic proceedings.

Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?

E. Bergstralh, E. Bergstralh, G. Thompson, 1998, Surgery.

The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012.

V. Montori, J. Brito, I. Hay, 2015, Thyroid : official journal of the American Thyroid Association.

Anaplastic thyroid carcinoma: a 50-year experience at a single institution.

G. Thompson, D. Giuffrida, I. Hay, 2001, Surgery.

The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition.

N. Eberhardt, M. Sahin, I. Hay, 2004, Oncogene.

The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition

N. Eberhardt, M. Sahin, J. G. Powell, 2004, Oncogene.

AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

H. Gharib, D. Duick, J. Garber, 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma

I. Hay, 2006, Journal of surgical oncology.

Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999.

L. Melton, A. Oberg, S. Achenbach, 2005, Mayo Clinic proceedings.

18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.

V. Lowe, C. Reading, J. Kasperbauer, 2008, Thyroid : official journal of the American Thyroid Association.

ATA Guidelines: do patients with stage I thyroid cancer benefit from (131)I?

I. Hay, I. McDougall, 2007, Thyroid : official journal of the American Thyroid Association.

Clinical Endocrine Oncology

I. Hay, J. Wass, 1997 .

Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma

G. Thompson, I. Hay, 2004, World Journal of Surgery.

Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance.

I. Hay, V. Fatourechi, 2000, Seminars in nuclear medicine.

THERAPEUTIC CONTROVERSY The Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer

M. Schlumberger, S. Sherman, L. Wartofsky, 1998 .

Chapter 36 – Thyroid Cancer

I. Hay, R. Foote, I. Petersen, 2012 .

Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms

D. Schaid, N. Eberhardt, D. Farley, 1993, World Journal of Surgery.

Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.

I. Hay, J. Goellner, J. Morris, 2001, The Journal of clinical endocrinology and metabolism.

Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy.

P. R. Dahl, D. Brodland, I. Hay, 1997, Journal of the American Academy of Dermatology.

Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970.

H. Gharib, E. Bergstralh, E. Bergstralh, 1992, Mayo Clinic proceedings.

Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008

M. Reinalda, G. Thompson, I. Hay, 2010, World Journal of Surgery.

Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies

V. Lowe, C. Reading, J. Kasperbauer, 2011, Nuclear medicine communications.

Effects of reducing the upper limit of normal TSH values.

M. Brennan, G. Klee, I. Hay, 2003, JAMA.

Thyroiditis: a clinical update.

I. Hay, 1985, Mayo Clinic proceedings.

18F-FDG PET of patients with Hürthle cell carcinoma.

V. Lowe, J. Kasperbauer, B. Mullan, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioiodine-induced hypothyroidism in Graves' disease: factors associated.

K. Offord, C. Gorman, I. Hay, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hypoglycemia during adrenergic beta-blockade: evidence against mediation via a deficiency of lactate for gluconeogenesis.

B. Frier, I. O'Brien, R. Corrall, 1985, Metabolism: clinical and experimental.

Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.

I. Hay, J. Goellner, W. Mcconahey, 2002, Transactions of the American Clinical and Climatological Association.

The Value of Positron Emission Tomography in the Surgical Management of Recurrent Papillary Thyroid Carcinoma

D. Farley, G. Thompson, B. Mullan, 2008, World Journal of Surgery.

The use of radioactive iodine in patients with papillary and follicular thyroid cancer.

M. Schlumberger, S. Sherman, L. Wartofsky, 1998, The Journal of clinical endocrinology and metabolism.

Need for a revised staging consensus in medullary thyroid carcinoma.

D. Farley, G. Thompson, T. Hoskin, 2009, Archives of surgery.

Papillary thyroid carcinoma.

I. Hay, 1990, Endocrinology and metabolism clinics of North America.

Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.

I. Hay, J. Ryan, J. Goellner, 1988, Surgery.

Biochemical testing of thyroid function.

G. Klee, I. Hay, George G. Klee, 1997, Endocrinology and metabolism clinics of North America.

CLINICAL CASE SEMINAR Familial Splenomegaly: Macrophage Hypercatabolism of Lipoproteins Associated with Apolipoprotein E Mutation (Apolipoprotein E (D149 Leu))

R. Mahley, I. Hay, T. Crotty, 2000 .

Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].

R. Mahley, I. Hay, T. Crotty, 2000, The Journal of clinical endocrinology and metabolism.

Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.

I. Hay, J. Morris, N. Jiang, 1988, Mayo Clinic proceedings.

Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors

David I. Smith, N. Eberhardt, I. Hay, 1998, Oncogene.

Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility.

G. Klee, I. Hay, 1987, The Journal of clinical endocrinology and metabolism.

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.

H. Gharib, D. Ilstrup, I. Hay, 1990, Annals of surgery.

FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance

N. Eberhardt, I. Hay, J. Goellner, 2000, Clinical endocrinology.

Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis.

G. Gleich, I. Hay, J. Goellner, 1996, The Journal of clinical endocrinology and metabolism.

The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E

D. Hodge, I. Hay, B. Kottke, 1997, Clinical endocrinology.

Thyroxine therapy in hypothyroid patients undergoing coronary revascularization: A retrospective analysis.

D. Duick, J. Maloney, I. Hay, 1981, Annals of internal medicine.

The Effects of Transforming Growth Factor-β on Growth and Differentiation of the Continuous Rat Thyroid Follicular Cell Line, FRTL-5

I. Hay, N. Jiang, G. Ranganathan, 1988 .

Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1).

R. Jenkins, I. Hay, C. Grant, 1991, Cancer genetics and cytogenetics.

Biochemical thyroid function testing.

G. Klee, I. Hay, 1994, Mayo Clinic proceedings.

METOCLOPRAMIDE INDUCED GROWTH HORMONE RELEASE IN HYPOGONADAL MALES

I. Hay, G. Beastall, J. Thomson, 1979, Clinical endocrinology.

Prognostic factors and management in thyroid cancer--consensus or controversy?

I. Hay, S. Grebe, 1996, The Western journal of medicine.

Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.

H. Gharib, A. Weaver, I. Hay, 1994, Surgery.

Effects of growth hormone, glucose and insulin on the factor VIII complex.

C. Forbes, G. Lowe, I. Hay, 1982, Thrombosis research.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

E. Bergstralh, E. Bergstralh, I. Hay, 1993, Surgery.

Follicular cell-derived thyroid carcinomas.

I. Hay, S. Grebe, 1997, Cancer treatment and research.

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.

L. Woolner, W. Taylor, I. Hay, 1986, Mayo Clinic proceedings.

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

M. Luster, S. Benvenga, S. Yamashita, 2015, Thyroid : official journal of the American Thyroid Association.

Thyroglossal duct carcinoma: report of 12 cases.

H. Heshmati, I. Hay, J. Goellner, 1997, Mayo Clinic proceedings.

Insular thyroid carcinoma in adolescents

I. Hay, J. Goellner, Ahmed A. K. Hassoun, 1997, Cancer.

Nontoxic Diffuse and Nodular Goiter and Thyroid Neoplasia.

S. Filetti, M. Schlumberger, I. Hay, 2008 .

Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.

T. Sebo, G. Thompson, I. Hay, 2008, Surgery.

Evidence for autoimmune mechanisms in the evolution of invasive fibrous thyroiditis (Riedel's struma)

I. Hay, A. Heufelder, 1994, The clinical investigator.

Extracervical fibrosclerosis causing obstruction of a ventriculo‐peritoneal shunt in a patient with hydrocephalus and invasive fibrous thyroiditis (Riedel's struma)

I. Hay, J. Goellner, C. Grant, 1997, Clinical endocrinology.

L‐Thyroxine contamination of pharmaceutical D‐thyroxine: Probable cause of therapeutic effect

C. Gorman, I. Hay, N. Jiang, 1984, Clinical pharmacology and therapeutics.

The Effects of Synthetic α-Subunit Peptides on Thyroid-Stimulating Immunoglobulin Activity*

I. Hay, N. Jiang, D. Mccormick, 1988 .

CHAPTER 11 – Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders

P. Larsen, M. Schlumberger, T. Davies, 2011 .

Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.

W. Taylor, I. Hay, C. Grant, 1987, Surgery.

Follicular cell-derived thyroid cancer

S. Franceschi, Y. Nikiforov, H. Dralle, 2015, Nature Reviews Disease Primers.

Columnar cell carcinoma of the thyroid: report of three additional cases.

R. Lloyd, I. Hay, J. Ferreiro, 1996, Human pathology.

Familial cytomegalic adrenocortical hypoplasia: an X-linked syndrome of pubertal failure.

I. Hay, P. Smail, C. Forsyth, 1981, Archives of disease in childhood.

Cytogenetic studies on 12 thyroid carcinomas

G. Dewald, R. Jenkins, I. Hay, 1989 .

Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.

D. Schaid, S. Thibodeau, S. Khosla, 1991, The Journal of clinical investigation.

PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value.

N. Eberhardt, M. Sahin, T. Sebo, 2005, The Journal of clinical endocrinology and metabolism.

Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

N. Eberhardt, H. Drabkin, R. Jenkins, 1997, The Journal of clinical endocrinology and metabolism.

Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.

M. Castro, J. Geske, A. Kotwal, 2020, Thyroid : official journal of the American Thyroid Association.

Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008.

T. Sebo, I. Hay, V. Fatourechi, 2011, Thyroid : official journal of the American Thyroid Association.

Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism.

J. Charboneau, C. Reading, G. Thompson, 1998, Surgery.

Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma.

J. Charboneau, I. Hay, J. V. van Heerden, 1988, Mayo Clinic proceedings.

Benign Hürthle cell tumors of the thyroid: A diagnosis to be trusted?

I. Hay, J. Goellner, C. Grant, 1988, World Journal of Surgery.

Value of Positron Emission Tomography in the Surgical Management of Recurrent Papillary Thyroid Carcinoma

I. Hay, C. Grant, 2008, World Journal of Surgery.

Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.

G. Thompson, I. Hay, C. Grant, 2014, The Journal of clinical endocrinology and metabolism.

Oncocytic tumours of the salivary gland, kidney, and thyroid: nuclear DNA patterns studied by flow cytometry.

L. Rainwater, G. Farrow, I. Hay, 1986, British Journal of Cancer.

FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.

N. Eberhardt, A. Yokomizo, D. Smith, 2000, Clinical endocrinology.

Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

S. Ritland, R. Jenkins, I. Hay, 1991, The Journal of clinical investigation.

Thyroid follicular carcinoma: sonographic features of 50 cases.

J. Mandrekar, J. Charboneau, C. Reading, 2010, AJR. American journal of roentgenology.

Prognostic indicators in differentiated thyroid carcinoma.

D. Dean, I. Hay, 2000, Cancer control : journal of the Moffitt Cancer Center.

Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.

E. Bergstralh, I. Hay, J. Goellner, 1991, Surgery.

Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

B. Delahunt, N. Eberhardt, I. Hay, 2002, The Journal of molecular diagnostics : JMD.

Low risk papillary thyroid cancer

J. Brito, I. Hay, J. Morris, 2014, BMJ : British Medical Journal.

Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.

E. Bergstralh, E. Bergstralh, G. Thompson, 1999, Surgery.

Hürthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behavior

E. Bergstralh, I. Hay, J. Ryan, 1992, World Journal of Surgery.

Management of patients with low-risk papillary thyroid carcinoma.

I. Hay, 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Semi-quantitative interpretation of the bone scan in metabolic bone disease

D. Citrin, I. Fogelman, I. Hay, 1979, European Journal of Nuclear Medicine.

Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values.

D. Citrin, I. Fogelman, I. Hay, 1980, The British journal of radiology.

Brain metastases from papillary thyroid carcinoma.

I. Hay, 1987, Archives of internal medicine.

18 F-FDG PET of Patients with Hu¨rthle Cell Carcinoma

V. Lowe, J. Kasperbauer, B. Mullan, 2003 .

Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?

I D Hay, E. Bergstralh, E. Bergstralh, 1988, Surgery.

Risks and Adequacy of an Optimized Surgical Approach to the Primary Surgical Management of Papillary Thyroid Carcinoma Treated During 1999–2006

C. Reading, G. Thompson, J. Stulak, 2010, World Journal of Surgery.

US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer.

J. Charboneau, C. Reading, I. Hay, 1988, Radiology.

THYROID FUNCTION, IODINE NUTRITION AND FETAL BRAIN DEVELOPMENT

I. Hay, B. Hetzel, 1979, Clinical endocrinology.

Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid

L. Rainwater, G. Farrow, I. Hay, 1988, World Journal of Surgery.

Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary?

E. Bergstralh, T. Habermann, A. Kunselman, 1992, World Journal of Surgery.

Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.

William D Middleton, P Reed Larsen, Mary C Frates, 2006, Radiology.

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

R. Smallridge, C. Erlichman, V. Suman, 2014, The Journal of clinical endocrinology and metabolism.

Mortality from papillary thyroid carcinoma: A case‐control study of 56 lethal cases

Steven A. Smith, I. Hay, J. Ryan, 1988, Cancer.

Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors

E. Bergstralh, L. Rainwater, I. Hay, 1990, World Journal of Surgery.

Role of thyrotropin measurements in the diagnosis and management of thyroid disease.

G. Klee, I. Hay, 1993, Clinics in Laboratory Medicine.

Assay for thyroid stimulating immunoglobulin.

I. Hay, V. Fairbanks, N. Jiang, 1986, Mayo Clinic proceedings.

Thyroid dysfunction.

G. Klee, I. Hay, 1988, Endocrinology and metabolism clinics of North America.

Nodular thyroid disease diagnosed during pregnancy: how and when to treat.

I. Hay, 1999, Thyroid : official journal of the American Thyroid Association.

Letter: Thyrotoxic periodic paralysis in Britain.

I. Mcdougall, I. Hay, 1975, British medical journal.

Stereospecific determination and in vivo monodeiodination of thyroxine enantiomers in euthyroid man.

C. Gorman, K. Burman, I. Hay, 1985, Metabolism: clinical and experimental.

Simultaneous determination of D- and L-thyroxine in human serum by liquid chromatography with electrochemical detection.

T. Annesley, C. Gorman, I. Hay, 1981, Journal of chromatography.

Cryosurgery or microsurgery in the management of acromegaly.

G. Teasdale, K. Grossart, J. Ratcliffe, 1982, JAMA.

Further evidence for autoimmune mechanisms in the pathogenesis of Riedel's invasive fibrous thyroiditis.

I. Hay, A. Heufelder, 1995, Journal of internal medicine.

Computer assistance: an essential for adrenal imaging.

H. Wahner, M. Brown, I. Hay, 1979, The British journal of radiology.

Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum.

P. Larsen, C. Mariash, J. Hershman, 1987, The Journal of clinical endocrinology and metabolism.

Chapter 38 – Thyroid Cancer

J. Brito, I. Hay, R. Foote, 2016 .

Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulking

A. Tefferi, G. Thompson, I. Hay, 1994, Cancer.

Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease.

G. Klee, I. Hay, 1993, Clinical chemistry.

Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study.

J. Brito, I. Hay, R. Giblon, 2021, Mayo Clinic proceedings.

Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas

J. Charboneau, C. Reading, T. Sebo, 2010, Journal of clinical ultrasound : JCU.

The role of surgery in the management of differentiated thyroid cancer

I. Hay, S. Grebe, 1997, Journal of Endocrinological Investigation.

Immunometric thyrotropin assays: current roles and future directions.

I. Hay, 1988, Mayo Clinic proceedings.

Graves' disease after unilateral Riedel's thyroiditis.

I. Hay, V. Fatourechi, B. Mciver, 2010, Journal of Clinical Endocrinology and Metabolism.

Thyroid cancer diagnosis and management.

G. Klee, I. Hay, 1993, Clinics in Laboratory Medicine.

Thyroid disorders, noncommunicable diseases that gravely impact public health: a commentary and statement by the Advisory Board of the World Thyroid Federation.

L. Duntas, R. Peeters, L. Ward, 2012, Thyroid : official journal of the American Thyroid Association.

Long-term Effectiveness of Ethanol Ablation in Controlling Neck Nodal Metastases in Childhood Papillary Thyroid Cancer

C. Reading, G. Thompson, I. Hay, 2023, Journal of the Endocrine Society.

METOCLOPRAMIDE STIMULATION: A TEST OF GROWTH HORMONE RESERVE IN ADOLESCENT MALES

I. Hay, G. Beastall, J. Thomson, 1979, Clinical endocrinology.

Familial resistance to thyroid hormone associated with decreased transport across the plasma membrane.

P. Davis, K. Burman, I. Hay, 1983, Annals of internal medicine.

Thyroiditis Mimicked by Metastatic Carcinoma to the Thyroid: Dr. Hay replies

I. Hay, 1986 .

Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

J. Garber, F. Wondisford, F. Brucker-Davis, 1997, The New England journal of medicine.

failure . X-linked syndrome of pubertal adrenocortical hypoplasia : an Familial cytomegalic

I. Hay, P. Smail, C. Forsyth, 2006 .

CONTRASTING EFFECTS OF SUBCUTANEOUS PULSATILE GnRH THERAPY IN CONGENITAL ADRENAL HYPOPLASIA AND KALLMANN'S SYNDROME

I. Hay, D. Gordon, G. Beastall, 1984, Clinical endocrinology.

Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma

I. Mcdougall, I. Hay, J. Sisson, 2008, Journal of Nuclear Medicine.

Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum.

P. Larsen, C. Mariash, J. Hershman, 1987, Archives of pathology & laboratory medicine.

A Multidisciplinary Study of the ‘Yips’ Phenomenon in Golf

Aynsley M. Smith, E. Laskowski, K. Kaufman, 2000, Sports medicine.

The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota

E. Kokmen, L. Kurland, K. Offord, 1991, Neurology.

Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?

G. Thompson, I. Hay, Suneetha Kaggal, 2022, European thyroid journal.

Clinical Endocrine Oncology

I. Hay, J. Wass, 1997 .

Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period.

I. Hay, J. Goellner, C. Grant, 1992, Surgery.

Chapter 38 – Thyroid Cancer

J. Brito, I. Hay, R. Foote, 2016 .